Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments
JAMA Network Open · 2025
DOI: 10.1001/jamanetworkopen.2025.38729 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift JAMA Network Open, 2025. Verfasst von Tess Stopczynski und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee. Hauptthemen laut MEDLINE: Influenza, Human, Antiviral Agents, Emergency Service, Hospital, Practice Patterns, Physicians'. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCIRD CDC HHS.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Importance Despite national recommendations, antiviral prescribing in emergency departments (EDs) for children at higher risk of severe influenza, such as those younger than 5 years and those with specific underlying conditions, remains low.
Objective
To assess whether there were changes in antiviral prescribing for children at higher risk of severe influenza in academic pediatric EDs before the COVID-19 pandemic (2016-2020) vs the late pandemic period (2021-2023). Design, Setting, and Participants This multicenter, cross-sectional study included influenza-positive children younger than 18 years presenting to the ED at 1 of 7 US pediatric academic hospitals participating in the Centers for Disease Control and Prevention’s New Vaccine Surveillance Network. The analysis focused on children at higher risk of severe influenza seen in the ED from December 1, 2016, to June 30, 2023. Exposure High risk of severe influenza. Main Outcomes and Measures The primary outcome was antiviral prescribing. Children with influenza who met the criteria for higher risk of severe influenza were included. Antiviral prescribing practices were compared across the prepandemic and late pandemic periods. Mixed-effects logistic regression was used to identify factors associated with prescribing during the late pandemic period.
Results
Of 3378 influenza-positive children (median [IQR] age, 3.9 [1.8-7.2] years), 2514 (74.4%; 1363 male [40.3%]) were classified as having higher risk of severe influenza during the prepandemic and late pandemic periods. Antiviral prescriptions decreased from 32.2% (622 of 1931 children) before the pandemic to 15.6% (91 of 583 children) in the late pandemic period, representing a 53% relative decrease. In the late pandemic period, symptom duration less than 2 days (adjusted odds ratio, 4.08; 95% CI, 2.49-6.71) and clinical influenza testing (adjusted odds ratio, 17.20; 95% CI, 4.08-72.37) were significantly associated with antiviral prescribing. Conclusions and Relevance This multicenter, cross-sectional study of children with influenza in EDs found that, for children at higher risk of severe influenza illness, influenza antiviral prescribing decreased during the COVID-19 pandemic compared with prepandemic levels, despite unchanged treatment guidelines. Interventions are needed to support guideline-concordant prescribing in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee.
- Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
- Seattle Children's Research Institute, Seattle, Washington.
- University of Rochester School of Medicine and Dentistry & UR-Golisano Children's Hospital, Rochester, New York.
- Department of Pediatrics, University of California, Los Angeles, Los Angeles.
- UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Förderung
- NCIRD CDC HHS
Zitieren
APA
Stopczynski, T., Hamdan, O., Amarin, J. Z., Antoon, J. W., Stewart, L. S., Hayek, H., Chappell, J., Spieker, A. J., Klein, E. J., Englund, J. A., Weinberg, G. A., Szilagyi, P. G., Williams, J. V., Michaels, M. G., Boom, J. A., Sahni, L. C., Staat, M. A., Schlaudecker, E. P., Schuster, J. E., …, & Halasa, N. B. (2025). Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2025.38729
Vancouver
Stopczynski T, Hamdan O, Amarin JZ, Antoon JW, Stewart LS, Hayek H, et al. Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments. JAMA Network Open. 2025. doi:10.1001/jamanetworkopen.2025.38729
BibTeX
@article{Stopczynski2025,
author = {Stopczynski, Tess and Hamdan, Olla and Amarin, Justin Z and Antoon, James W and Stewart, Laura S and Hayek, Haya and Chappell, James and Spieker, Andrew J and Klein, Eileen J and Englund, Janet A and Weinberg, Geoffrey A and Szilagyi, Peter G and Williams, John V and Michaels, Marian G and Boom, Julie A and Sahni, Leila C and Staat, Mary Allen and Schlaudecker, Elizabeth P and Schuster, Jennifer E and Selvarangan, Rangaraj and Tannis, Ayzsa and Moline, Heidi L and Olson, Samantha M and Halasa, Natasha B},
title = {Changes in Antiviral Prescribing for Children With Influenza in US Emergency Departments},
journal = {JAMA Network Open},
year = {2025},
doi = {10.1001/jamanetworkopen.2025.38729}
}
EUVIMED